Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia

Authors: Aypara Hasanova, Chingiz Asadov, Nigar Karimova, Aytan Shirinova, Gunay Aliyeva, Zohra Alimirzoyeva

Source: Pathology and Oncology Research, Vol 29 (2023)

Subject Terms: chronic myeloid leukemia, mutation, tyrosine kinase inhibitor resistance, kinase domain, BCR-ABL, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Pathology, RB1-214

File Description: electronic resource

Relation: https://www.por-journal.com/articles/10.3389/pore.2023.1611518/full; https://doaj.org/toc/1532-2807

Access URL: https://doaj.org/article/ad664eb81df5488ca2e95a1c659f0f90

Imatinib-resistance without BCR/ABL Point Mutation in Chronic Myeloid Leukemia

Authors: Aytan Shirinova

Source: Caucasian Medical Journal, Vol 2, Iss 1, Pp 1-2 (2024)

Subject Terms: imatinib-resistance, cml, abl1 domain mutations, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/2980-1818

Access URL: https://doaj.org/article/d19cd61d5c704ceb82f2a3b96da3241e